RhumbLine Advisers’s Pardes Biosciences, Inc. Common Stock PRDS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-5,832
| Closed | -$10.6K | – | 4403 |
|
|
2023
Q2 | $10.6K | Sell |
5,832
-43,223
| -88% | -$78.2K | ﹤0.01% | 3939 |
|
|
2023
Q1 | $65K | Buy |
49,055
+2,527
| +5% | +$3.35K | ﹤0.01% | 2896 |
|
|
2022
Q4 | $79K | Buy |
46,528
+891
| +2% | +$1.51K | ﹤0.01% | 2919 |
|
|
2022
Q3 | $84K | Buy |
45,637
+4,564
| +11% | +$8.4K | ﹤0.01% | 3019 |
|
|
2022
Q2 | $126K | Buy |
+41,073
| New | +$126K | ﹤0.01% | 3013 |
|